FibroGen, Inc. Gains 37.44%

Thu, Feb 20, 2025 at 07:31 PM

FibroGen, Inc. (FGEN:NASDAQ) soared at $0.77, representing a gain of 37.4%. On Thu, Feb 20, 2025, FGEN:NASDAQ touched a New 2-Week High of $0.77. The stock got featured on our News Catalysts scanner on Thu, Feb 20, 2025 at 08:33 AM in the 'ACQUISITION' category. From Thu, Feb 06, 2025, the stock recorded 44.44% Up Days and 30.00% Green Days

About FibroGen, Inc. (FGEN:NASDAQ)

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

Top 10 Gainers:

Mobile-health Network Solutions (MNDR:NASDAQ), 185.08%
Xos Inc. (XOS:NASDAQ), 96.54%
Volato Group Inc. Class A (SOAR:NYSEMKT), 49.25%
Sharps Technology Inc. (STSS:NASDAQ), 44.77%
Herbalife Nutrition Ltd. (HLF:NYSE), 42.7%
Aureus Greenway Holdings Inc. (AGH:NASDAQ), 41.71%
YSX Tech. Co. Ltd (YSXT:NASDAQ), 39.44%
FibroGen, Inc. (FGEN:NASDAQ), 37.44%
SRAX, Inc. (SRAX:NASDAQ), 33.33%
ProLung, Inc. (LUNG:NASDAQ), 32.23%